Covid-19 Research articles 

  1. Babu GR, Ray D, Bhaduri R, Halder A, Kundu R, Menon GI, Mukherjee B. COVID-19 Pandemic in India: Through the Lens of Modeling. Global Health: Science and Practice. 2021 Jun 7.
  2. K Srinath Reddy, Giridhara Babu, Chandrika B, Nirupam B, Malay B, Dhruva C, Lancet Covid-19 Commission India Task Force for Managing Second Wave – Urgent Steps, April 2021
  3. Manoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, V Saravanakumar, Jeromie Wesley Vivian Thangaraj, Naman Shah, et al. SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey,. January 27, 2021 DOI:https://doi.org/10.1016/S2214-109X(20)30544-1
  4. Giridhara R. Babu, Sonalini Khetrapal, Daisy A. John, R. Deepa, K.M. Venkat Narayan, Pandemic Preparedness and Response to COVID-19 in South Asian Countries, International Journal of Infectious Diseases, ISSN 1201-9712, https://doi.org/10.1016/j.ijid.2020.048.
  5. Athreya S, Babu GR, Iyer A, Rathod N, Shriram S, Sundaresan R, Vaidhiyan NK, Yasodharan S. COVID-19: Optimal Design of Serosurveys for Disease Burden Estimation. arXiv preprint arXiv:2012.12135. 2020 Dec 22.
  6. Narendra Kumar, Shafeeq K S Hameed, Giridhara R Babu, Manjunatha M Venkataswamy, Prameela Dinesh, Prakash B G Kumar, Daisy A John, Anita Desai, Ravi Vasanthapuram. Epidemiology of SARS-CoV-2 infection in Karnataka State, South India: Transmission dynamics of symptomatic vs. asymptomatic infections. medRxiv 020.09.17.20196501; doi: https://doi.org/10.1101/2020.09.17.20196501
  7. Murhekar MV, Bhatnagar T, Selvaraju S, Rade K, Saravanakumar V, Vivian Thangaraj JW, Kumar MS, Shah N, Babu GR, et al, SARS-CoV-2 antibody prevalence in India: Findings from the second nationwide household serosurvey, August – September 2020, DOI: 10.2139/ssrn.3715460
  8. Babu GR, Sundaresan R, Athreya S, Akhtar J, Pandey PK, Maroor PS, et al. The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India. 2020.
  9. Murhekar MV, Bhatnagar T, Selvaraju S, Rade K, Saravanakumar V, Vivian Thangaraj JW, Kumar MS, Shah N, Babu GR, et al, for India COVID-19 Serosurveillance Group. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. Indian J Med Res
  10. Sanit Gupta, Sahil Shah, Sumit Chaturvedi, Pranav Thakkar, Parvinder Solanki, Aritra Das, Giridhara R Babu, et al. An India-specific Compartmental Model for Covid-19: Projections and Intervention Strategies by Incorporating Geographical, Infrastructural and Response Heterogeneity. arXiv preprint arXiv:2007.14392.
  11. V Venkata S Ram, Giridhara R Babu, Dorairaj Prabhakaran, COVID-19 pandemic in India: Is the curve now flat?, Euro. Heart Journal, https://doi.org/10.1093/eurheartj/ehaa493
  12. Priya Abraham, Neeraj Aggarwal, Giridhara R Babu, Suganya Barani, Balram Bhargava, Tarun Bhatnagar, et al. Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 – April 30, 2020 Indian Journal of Medical Research. 2020;151(5) :424-37
  13. Thakur M, Boudewijns EA, Babu GR, van Schayck OC. Biomass use and COVID-19: A novel concern. Environmental Research. 2020:109586

 

Global Health in Action: Hear from Dr. Giridhara R Babu on Transforming Population Health